SEE FULL COMPANY PROFILES WITH A FREE TRIAL
EMIS is the definitive emerging markets news, research, company, and financial data resource. EMIS - ISI Emerging MarketsLEARN MORE
Search for another company:
ALL
India
Company data displayed is for sample purposes only and may not reflect the most current information available on Emerging Markets Information Service (EMIS).

Anuh Pharma Ltd.

Main Activities: Chemical Manufacturing - Health and Personal Care Stores

facebook Please check the full coverage of information what EMIS can offer you. SEE SAMPLE

Company Information

Full name
Anuh Pharma Ltd.

Headquarters
A-3, Shivsagar Estate, North Wing, Dr. Annie Besant Road, Worli; Mumbai; Maharashtra; 400018
Legal Address
3-A, Dr. Annie Basant Road, Shiv Sagar Estate, North Wing, Worli; Mumbai; Maharashtra; 400018
Status: Listed
Legal Form: Public Limited Company
Operational Status: Operational
ISIN CODE : INE489G01022
Financial Auditors: S I Mogul & Co (2011)

Tel: 022- 66227575

Company Description

The company was incorporated in 1960. It manufactures antibiotics and metallic stearates. The plant is located at Thane in Maharashtra.
As of June 2003, promoters held around 89 percent of the equity in the company. The company is promoted by Bipi

Company Analysis

According to the Individual - Audited financial statement for the Year of 2012, total net operating revenues increased with 27.97%, from INR 179.03 tens of millions to INR 229.11 tens of millions. Operating result increased from INR 16.16 tens of millions to INR 20.58 tens of millions which means 27.35% change. The results of the period increased 4.56% reaching INR 12.85 tens of millions at the end of the period against INR 12.29 tens of millions last year. Return on equity (Net income/Total equity) went from 18.78% to 18.57%, the Return On Asset (Net income / Total Asset) went from 18.00% to 18.54% and the Net Profit Margin (Net Income/Net Sales) went from 6.86% to 5.61% when compared to the same period of last year. The Debt to Equity Ratio (Total Liabilities/Equity) was 0.17% compared to 10.73% of last year. Finally, the Current Ratio (Current Assets/Current Liabilities) went from 1.48 to 1.50 when compared to the previous year.

Key Executives

Mr. G C Sharda Chief Executive Director
Mr. Vivek Shah Chief Executive Director
Mr. Jitendra Shah Vice President - Marketing
Mr. Raju Kotadia Vice President - Technical
Mr. Arun Todarwal Director
More

Companies with Similar Main Activities

ISI Emerging Markets

FULL COMPANY PROFILE

Please check the full coverage of information what EMIS can offer you.
SEE SAMPLE
SELECT CURRENCY
Balance Sheet

Shareholders Equity

4

4

* All the accounts are in INR.
Income Statement

Total Operating Revenue

118

65

Operational Profit (Loss)

9

4

Net Profit (Loss)

7

3

* All the accounts are in INR.
Ratios
Profitability Ratios

Return on Equity (ROE)

174.88%

88.28%

Annualised Return on Equity (ROE)

349.76%

353.12%

Return on Sales (ROS)

100%

100%